Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01292733 · ClinicalTrials.gov registry record · Early Phase 1
Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
A Early Phase 1 study, sponsored by Swedish Medical Center.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 534
- Enrollment target
NCT01292733 is a Early Phase 1 study that was terminated before completion, run by Swedish Medical Center. The registered enrollment target is 534 participants.
The verdict
NCT01292733, a Early Phase 1 study, was terminated before completion, sponsored by Swedish Medical Center.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 534 participants
- Enrollment target
Study Summary
The main purpose of this program is to see whether periodically measuring CA-125 (tumor marker) levels in the blood and undergoing transvaginal ultrasounds over time will be effective in the early detection of ovarian cancer.
Interventions
- OTHER Laboratory Tumor Marker Analysis
- OTHER Transvaginal Ultrasound
- OTHER Health Status Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 534 participants |
| Start Date | 2009-08 |
| Est. Completion | 2015-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01292733
The ClinicalTrials.gov registry entry for NCT01292733 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 534 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Swedish Medical Center, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Laboratory Tumor Marker Analysis is the first listed.
NCT01292733 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01292733 about?
NCT01292733 is a clinical study titled "Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer". The main purpose of this program is to see whether periodically measuring CA-125 (tumor marker) levels in the blood and undergoing transvaginal ultrasounds over time will be effective in the early detection of ovarian cancer.
What is the current status of trial NCT01292733?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 534 participants. The study started on 2009-08. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01292733?
The interventions under investigation include: Laboratory Tumor Marker Analysis (OTHER), Transvaginal Ultrasound (OTHER), Health Status Questionnaire (OTHER).
Who is sponsoring clinical trial NCT01292733?
This trial is sponsored by Swedish Medical Center, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.